Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation

BACKGROUND: Type 2 Diabetes mellitus (T2DM) is a common comorbidity in patients after heart transplantation (HTx) and is associated with adverse long-term outcomes. METHODS: The retrospective study reported here analyzed the effects of vildagliptin therapy in stable patients post-HTx with T2DM and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gueler, Ibrahim, Mueller, Susanne, Helmschrott, Matthias, Oeing, Christian U, Erbel, Christian, Frankenstein, Lutz, Gleißner, Christian, Ruhparwar, Arjang, Ehlermann, Philipp, Dengler, Thomas J, Katus, Hugo A, Doesch, Andreas O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623547/
https://www.ncbi.nlm.nih.gov/pubmed/23630415
http://dx.doi.org/10.2147/DDDT.S43092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623547/
https://www.ncbi.nlm.nih.gov/pubmed/23630415
http://dx.doi.org/10.2147/DDDT.S43092

Ejemplares similares